Primene 10 % inf. sol. i.v.

Pays: Belgique

Langue: anglais

Source: AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

Ingrédients actifs:

Cysteine 1,89 g/1000 ml; Taurine 0,6 g/1000 ml; Methionine 2,4 g/1000 ml; Valine 7,6 g/1000 ml; Tryptophan 2 g/1000 ml; Phenylalanine 4,2 g/1000 ml; Threonine 3,7 g/1000 ml; Isoleucine 6,7 g/1000 ml; Glycine 4 g/1000 ml; Leucine 10 g/1000 ml; Proline 3 g/1000 ml; Lysine 11 g/1000 ml; Glutamic Acid 10 g/1000 ml; Alanine 8 g/1000 ml; Aspartic Acid 6 g/1000 ml; Serine 4 g/1000 ml; Tyrosine 0,45 g/1000 ml; Ornithine Hydrochloride 3,18 g/1000 ml; Arginine 8,4 g/1000 ml; Histidine 3,8 g/1000 ml

Disponible depuis:

Baxter SA-NV

Code ATC:

B05BA10

DCI (Dénomination commune internationale):

Cysteine Hydrochloride; Glycine; Histidine; Glutamic Acid; Methionine; Isoleucine; Leucine; Lysine; Proline; Phenylalanine; Ornithine; Tyrosine; Tryptophan; Threonine; Taurine; Serine; Alanine; Arginine; Aspartic Acid; Valine

Dosage:

10 %

forme pharmaceutique:

Solution for infusion

Composition:

Cysteine Hydrochloride 2.46 mg/ml; Glycine 4 mg/ml; Histidine 3.8 mg/ml; Glutamic Acid 10 mg/ml; Methionine 2.4 mg/ml; Isoleucine 6.7 mg/ml; Leucine 10 mg/ml; Lysine 11 mg/ml; Proline 3 mg/ml; Phenylalanine 4.2 mg/ml; Ornithine 2.49 mg; Tyrosine 0.45 mg/ml; Tryptophan 2 mg/ml; Threonine 3.7 mg/ml; Taurine 0.6 mg/ml; Serine 4 mg/ml; Alanine 8 mg/ml; Arginine 8.4 mg/ml; Aspartic Acid 6 mg/ml; Valine 7.6 mg/ml

Mode d'administration:

Intravenous use

Domaine thérapeutique:

Combinations

Descriptif du produit:

CTI code: 142073-01 - Pack size: 250 ml - Commercialisation status: YES - CNK code: 0664045 - Delivery mode: Medical prescription; CTI code: 141906-01 - Pack size: 1000 ml - Commercialisation status: NO - Delivery mode: Medical prescription; CTI code: 141915-01 - Pack size: 100 ml - Commercialisation status: YES - CNK code: 0664037 - Delivery mode: Medical prescription

Statut de autorisation:

Commercialised: No

Date de l'autorisation:

1988-05-24